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rehabilitation on anxiety and depression
in hospitalized COPD patiens
G. Garuti, C. Cilione, D. Dell’Orso, P. Gorini*, 
M.C. Lorenzi, L. Totaro, G. Cirelli, E. Clini
Introduction
Chronic Obstructive Pulmonary Disease
(COPD) is a disorder commonly associated with
disability and impaired quality of life [1]. Patients
with COPD have been shown to refer symptoms of
raised anxiety and depression [2], the most severe
patients being those presenting the highest levels
of depression, which also appears to be under-rec-
ognized and under-treated [3].
Pulmonary rehabilitation (PR) is increasingly
used to treat COPD patients of different degree of
severity [4], bringing them benefits in terms of im-
proved exercise capacity and quality of life  [1, 5].
Some evidence also suggests that a shorter inpa-
tient PR (iPR) is as useful and effective as a longer
outpatient PR [6]. Furthermore, it has been shown
that a short-stay iPR can improve psychological
morbidity in patients with COPD [7]. Indeed, out-
patient PR significantly improved the levels of
anxiety and depression of COPD patients with a
FEV1 lower than 40% of predicted value [8].
Still little is known about the effect of iPR on
anxiety and depression in patients with less severe
functional compromission and after acute exacer-
bation of their disease.
We therefore aimed to evaluate the impact of a
short-stay iPR on anxiety and depression as out-
come measures in patients with both moderate or
severe COPD after an acute exacerbation.
Methods
Patients gave their informed consent to the
study. All the procedure were conducted according
to the declaration of Helsinki.
Patients
Patients with COPD consecutively admitted to
our rehabilitation unit from July, 1st to December
31st, 2000 were studied. They were referred direct-
ly from acute care hospitals following an acute ex-
acerbation of their disease. At the admission all pa-
tients were in stable condition as defined by stabil-
ity in blood gas values. At this time none of the pa-
tients received systemic steroids; no change in the
treatment with inhaled bronchodilators and steroid
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To prospectively evaluate the effect of inpatient pul-
monary rehabilitation (iPR) on anxiety and depression as
outcome measures in patients with COPD, we studied 149
consecutive adults COPD referred to our iPR after an ex-
acerbation. Patients were divided according to the GOLD
staging into: Group 1 (stage 2a, n=48, FEV1 63±9 %pred.),
Group 2 (stage 2b, n=53, FEV1 42±6 %pred.) and Group
3 (stage 3, n=48, FEV1 25±7 %pred.). The iPR consisted of
twelve 3-hours daily sessions.  
Hospital Anxiety Depression (HAD) Scale as well as 6-
minute walk (6MWD) with evaluation of dyspnea (D) and
leg fatigue (F) at rest and end of effort, and health related
quality of life by means of St. George Respiratory Ques-
tionnaire (SGRQ) were assessed before (T0) and after (T1)
the iPR.
6MWD, D and F at end of effort and SGRQ total score
similarly improved (p<0.001) in all groups after iPR. The
mean level of HAD-anxiety (from 9.1±4.0 to 7.7±3.5, from
9.0±4.6 to 7.2±4.6 and from 8.1±4.1 to 6.7±4.3 in group 1,2 and
3 respectively) and HAD-depression (from 9.4±3.5 to 8.2±3.5,
from 9.1±4.2 to 8.2±4.5 and from 9.0±4.0 to 7.4±4.5 respec-
tively) similarly changed (p<0.0001) over time in all groups.
The total percentage of patients with abnormal score (>10) of
HAD-anxiety (from 31% to 21%) and HAD-depression (from
30% to 22%) significantly decreased (p<0.05) after the iPR.
Inpatient pulmonary rehabilitation may improve lev-
els of anxiety and depression as well as symptoms, exercise
capacity and health related quality of life in moderate to
severe COPD patients after an acute exacerbation.
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(when appropriate) had been made in the six days
preceding the admission to our hospital.
Eligibility criteria for iPR at this facility were:
persisting symptomatic disease after exacerbation
(e.g. dyspnea score ≥ 2 at the MRC scale), degree
of disability and actual inability to perform most
activity of daily living precluding participation to
a outpatient program, FEV1 lower than 80% ofpredicted and a FEV1/FVC ratio below 70%, arte-
rial PO2 ≥ 60 mmHg breathing room air at rest,
sufficient motivation and endurance to participate
the rehabilitation therapy daily. Patients with any
unstable medical condition, severe left ventricular
dysfunction, resting hypoxemia, cancer, or inabili-
ty to cooperate were excluded from the study.
The included patients were diagnosed and
classified as COPD according to the GOLD stag-
ing and definition [9] and they were so divided in-
to: Group 1 (stage 2a, n=48, FEV1 63±9% pred.),Group 2 (stage 2b, n=53, FEV1 42±6% pred.) andGroup 3 (stage 3, n=48, FEV1 25±7% pred.). All
the included COPD patients had history of smok-
ing (>20 pack-year) but they currently were non-
smokers or ex-smokers.
Measurements
Functional measures
Baseline lung volumes and Forced Vital Ca-
pacity (FVC) were measured by means of a
spirometer (Masterscope Jaeger GmbH, Hochberg-
Germany). The predicted values according to
QUANJER [10] were used. Arterial blood was sam-
pled at the radial artery while the patients in the sit-
ting position were breathing room air for at least
one hour. PaO2, PaCO2 and pH were measured by
means of an automated analyzer (Mod. 850, Chiron
Diagnostics Co., Medfield-USA). Respiratory
muscle strength was assessed by measuring MIP
and MEP [11] using a respiratory module system
(Masterscope PIMAX/PEMAX Module, Jaeger
GmbH, Hochberg-Germany). The predicted values
according to BRUSCHI et al. [12] were used.
Outcome measures
Measurement were taken baseline (T0) and at
the end of iPR (T1). All measurements were per-
formed and recorded under the supervision of per-
sonnel not involved in the study.
The timed walk distance was assessed by the 6
minute walking test (6MWD) [13] while patients
breathed room air. Verbal encouragement was giv-
en at definite intervals during the test. Three prac-
tice tests were performed on 2 consecutive days
and the highest value was recorded. Arterial oxy-
gen saturation (SatO2) was indirectly monitored
throughout the walk using a pulse oximeter. Per-
ceived dyspnea (D) and leg fatigue (F) by pointing
a number or phrase on a 10-point modified Borg
scale [14] were obtained before (Resting) and im-
mediately following (End of effort) the walk test.
Levels of anxiety and depression were mea-
sured using the Hospital Anxiety and Depression
(HAD) Scale [15]. This is a equally divided 14
four-point questions scale: answers result into two
separate scores (ranging from 0 to 21) for anxiety
(HAD-anxiety) or depression (HAD-depression).
Health related quality of life was assessed by
the validated Italian versions of the St. George’s
Respiratory Questionnaire (SGRQ) [16]: the four
component scores (Total, Impact, Activity, Symp-
toms) of the questionnaire were considered for
analysis.
Inpatient Pulmonary Rehabilitation
Our iPR is performed in patients admitted to a
85 bed ward. After initial evaluation by physician
and respiratory therapist, a multidisciplinary team
(consisting of chest physician, nurses, physical ther-
apist, dietician and psychologist) assessed the patient
thus formulating an individualized rehabilitation
plan. Patients performed 12 sessions (6 days per
week) which were held for 3 hours on a day basis.
All patients were instructed for compensatory
breathing techniques, energy conservation, stress
management and symptoms control. Moreover
iPR included optimization of the pharmacological
treatment.
Each session included: gait and balance train-
ing, supervised floor walking and stationary bicy-
cle exercise, stair climbing, abdominal, upper and
lower limb muscle activities lifting progressively
light weights (300-500 gms), shoulder and full arm
circling, instruction in activities of daily living and
therapeutic recreation focused on community re-
entry, psychosocial counseling, nutritional pro-
grams (when appropriate). 
Exercises were discontinued if vital signs, satura-
tion or other parameters resulted inappropriate or
dangerous to the patient; therapeutic oxygen was
prescribed (if required) to protect against an in-
creased oxygen demand. No assisted ventilation
was used with any of the patients in study.
The scheduling of the rehabilitative therapies
was organized with the goal to discharge the pa-
tient to independent function at the end of the pro-
grammed sessions.
Statistical analysis
Results are expressed as mean and standard
deviation (SD). All analyses were performed using
a specific software (StatSoft package 5.0 for Win-
dows). Physiological data were analysed between
and within groups with Anova for repeated mea-
sures; post-hoc test was then applied when appro-
priate. To detect between groups differences for
non-parametric variables, the Kruskal-Wallis test
was used, while the Friedman non-parametric test
was used to detect differences within group (time
course). A score of 10 or greater for HAD scores
was taken as suggestive of clinically significant
anxiety or depression [15]. Frequency distribu-
tions were analysed with χ2 test. Spearman analy-
sis was used to evaluate the linear correlation co-
efficient between the considered parameters. A p
value <0.05 was considered to be significant.
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Results
The 149 COPD patients who entered the study
represented 34% of the total patients consecutive-
ly admitted to our ward for rehabilitative purpose
in the considered period.
Table 1 shows the general and demographic
characteristics of patients in study divided into
groups according to the GOLD staging (see Meth-
ods). Groups significantly differed for the level of
airflow obstruction due to the pre-determined def-
inition: nevertheless, the level of respiratory mus-
cle strength was also significantly dif-
ferent across groups. Out of 149 pa-
tients, only 14 (9% of total, 4, 4 and 6
patients in group 1, 2 and 3 respec-
tively) were taking antidepressant
drug.
At baseline group 3 showed a sig-
nificantly lower 6MWD (p<0.05 ver-
sus group 1 and 2) and higher D and
F at end of effort (p<0.01 versus
group 1) (see table 2).
Table 2 also shows the time
course of symptoms and exercise ca-
pacity in the considered groups; the
iPR determined a similar improve-
ment in all groups when comparing
the same outcome measures before
(T0) and after (T1) the program.
Table 3 shows the time course of
SGRQ and HAD mean scores in the
three groups. All groups showed a
similar improvement over time for
HAD-anxiety and HAD-depression
scores and for the SGRQ total score
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Table 1. - Demographic, anthropometric and functional characteristics
of patients at study entry. Data are as means (SD)
Group 1 Group 2 Group 3 p (Anova)
Patients (n) 48 53 48 ns
Sex (M/F) 30/18 33/20 31/17 ns
Age (years) 70 (7) 68 (8) 68 (7) ns
BMI (Kg x cm-2) 24 (3) 25 (4) 23 (6) ns
FEV1 (% pred) 63 (9) 42 (6) 25 (7) < 0.001
FVC (% pred) 81 (13) 63 (12) 48 (12) < 0.001
FEV1/VC 68 (9) 57 (11) 46 (17) < 0.001
MIP (cm H2O) 55 (24) 46 (22) 49 (24) < 0.05
MEP (cm H2O) 83 (34) 78 (30) 71 (27) < 0.05
PaCO2 (mmHg) 39 (4) 40 (5) 42 (5) ns
PaO2 (mmHg) 68 (10) 69 (10) 63 (11) ns
BMI: Body Mass Index; FEV1 : pre-bronchodilator Forced Expiratory 
Volume in one second; FVC: pre-bronchodilator Forced Vital Capacity; MIP
= Maximal Inspiratory Pressure; MEP = Maximal Expiratory Pressure;
PaO2: Arterial Oxygen Tension; PaCO2: Arterial Carbon dioxide Tension.
Table 2. - Time course of symptoms and exercise capacity of patients in study. Data are as means (SD)
Group 1 Group 2 Group 3
T0 T1 T0 T1 T0 T1
6MWD (meters) 361 (89) 429 (85) * 328 (113) 404 (101) * 272 (111) + 357 (106) *
End of effort-D 4.9 (1.3) 2.4 (1.3) § 5.3 (1.4) 3.0 (1.6) § 5.6 (1.5) ° 3.5 (2.3) §
End of effort-F 5.5 (1.4) 3.6 (1.3) § 6.0 (2.1) 4.3 (1.5) § 6.4 (1.1) ° 4.8 (2.0) §
Resting-D 3.6 (1.9) 3.5 (2.0) 4.0 (2.0) 4.0 (1.7) 4.1 (2.4) 3.9 (1.5)
Resting-F 3.7 (2.2) 3.8 (1.5) 3.9 (1.8) 4.1 (2.1) 4.0 (2.1) 3.8 (2.2)
6MWD: six minute walking capacity; End of effort-D: BORG score for dyspnea after exercise; End of effort-F: BORG score
for leg fatigue after exercise; Resting-D: BORG score for dyspnea before exercise; Resting-F: BORG score for leg fatigue 
before exercise. * p<0.0001 versus T0; § p<0.001 versus T0; + p<0.05 versus group 1 and 2; ° p<0.01 versus group 1.
Table 3. - Time course of anxiety / depression and health related quality of life of patients in study. Data are as
means (SD)
Group 1 Group 2 Group 3
T0 T1 T0 T1 T0 T1
HAD-anxiety 9.1 (4.0) 7.7 (3.5) * 9.0 (4.6) 7.2 (4.6) * 8.1 (4.1) 6.7 (4.3) *
HAD-depression 9.4 (3.5) 8.2 (3.5) * 9.1 (4.2) 8.2 (4.5) * 9.0 (4.0) 7.4 (4.5) *
SGRQ-Total 53 (17) 48 (18) * 53 (18) 44 (20) * 60 (18) 53 (19) *
SGRQ-Impact 46 (22) 42 (22) 44 (20) 37 (22) 54 (21) 48 (23) 
SGRQ-Activity 68 (18) 63 (19) 68 (19) 62 (22) 73 (20) 67 (23) 
SGRQ-Symptoms 48 (23) 44 (25) § 50 (23) 37 (22) § 54 (22) 44 (23) §
HAD-anxiety: patients’ anxiety level at the Hospital Anxiety Depression Scale; HAD-depression: patients’ depression level at
the Hospital Anxiety Depression Scale; SGRQ: St.George Respiratory Questionnaire. * p<0.0001 versus T0; § p<0.05 versus T0.
(p<0.0001), the latter being mainly due to the sig-
nificant change in the SGRQ symptoms compo-
nent.
At T0 an abnormal level (>10) for both HAD-
anxiety and HAD-depression scores was recorded
in 31 and 30% respectively of the total sample. At
this time, no significant differences were recorded
among groups for an abnormal level (>10) of HAD-
anxiety and HAD-depression scores. Figure 1 shows
the frequency distribution of all patients according
to the HAD scores at T0 and T1. The mean im-
provement in HAD-anxiety score was 1.4, 1.8 and
1.4 in group 1, 2 and 3 respectively, whereas HAD-
depression score improved by 1.2, 0.9 and 1.6 re-
spectively. The chi-square analysis showed a statis-
tically significant difference (p<0.05) in the total
number and percentage of patients with abnormal
level of HAD-anxiety (which decreased from 51%
to 35% and from 31% to 21%) and HAD-depres-
sion (which decreased from 50% to 38% and from
30% to 22%) before and after iPR. At T1, the num-
ber of patients with an abnormal score differently
changed in group 1,2 and 3 (p<0.05) for HAD-anx-
iety (+5, -13 and -8%, respectively) and HAD-de-
pression (-4, -8 and -10%).
The physiologic outcome measurements
(symptoms and exercise capacity) did not show
significant correlation with HAD-anxiety or HAD-
depression scores at any time. HAD-anxiety and
HAD-depression scores slightly but significantly
(p<0.05) related with SGRQ total score both at T0
(r=.42 and r=.41 respectively) and T1 (r=.53 and
r=.49 respectively). Moreover, % change in SGRQ
total score also significantly, although weakly, re-
lated with % change in HAD-anxiety (r=.20,
p<0.05), but not HAD-depression, score.
Discussion
This prospective study has demonstrated that a
12-sessions iPR can provide similar improvement
in anxiety and depression as well as in exercise ca-
pacity and symptoms in both moderate or severe
COPD patients after an acute exacerbation.
Overall, the value of pulmonary rehabilitation
in COPD patients has been generally well estab-
lished [9]. The relative efficacy of the specific
components of this comprehensive program on
physiological and psychological health has still to
be definitively clarified in these patients. Our
study shows that COPD patients of different sever-
ity may benefit from iPR in terms of physical per-
formance and health-related quality of life, thus
confirming previous results in COPD of different
severity both as outpatients [4] or inpatients [7]. At
the best of our knowledge, this is the first study
documenting that a twelve daily sessions iPR may
also improve levels of anxiety and depression in
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Fig. 1. - Frequency distribution of HAD-anxiety (upper panels) and HAD-depression (lower panels) scores at T0 (left) and T1 (right).
COPD patients with moderate and severe stage of
their disease after an acute exacerbation.
Previous studies have documented high levels
of anxiety and depression in these patients [5, 17,
18]. In particular, depressive symptoms are more
prevalent in COPD patients than in age-matched
subjects from a general population [19] and signif-
icantly contribute to the overall variance in func-
tional status of the disease [20]. VOTTO et al. [7]
have been able to show that a limited series of se-
verely disabled (FEV1 below 50% of predicted)COPD inpatients may decrease their anxiety and
depression as assessed by means of partial compo-
nents of the Pulmonary Functional Status Scale
(PFSS) [21] after a short-term comprehensive re-
habilitation program.
The HAD scale, that we use in our study, has
been previously validated as the best tool for use in
assessment of psychosocial morbidity [15] and
provides more specific information as compared
with other means to assess anxiety and depression
[21, 22].
HAD scale has been used by WITHERS et al. [8]
to test the individual’s response to PR in stable se-
vere COPD (FEV1 below 40% of predicted) enter-ing an outpatients program: they were able to
demonstrate that both anxiety and depression sig-
nificantly improved following PR, and that the
levels reached by the HAD scores were maintained
lower over 6 months. In our opinion, the present
results extend those of that study [8], by showing
that multidisciplinary PR may decrease the HAD
levels in COPD inpatients following an acute ex-
acerbation independent of the degree of severity.
The mean improvements in HAD-anxiety
score (1.4, 1.8 and 1.4 in group 1, 2 and 3 respec-
tively) and in HAD-depression score (1.2, 0.9 and
1.6, respectively) were higher than those observed
in the whole population of the Withers study [8].
This effect may be mainly due to the different pop-
ulations studied; our COPD patients followed an
acute episode requiring hospitalization and base-
line HAD scores were higher than those of WITH-
ERS et al. [8]. Indeed, hypoxaemia per se may re-
duce ability to face the activity of daily living, im-
pair cognitive function [23] and increase depres-
sion [3] of COPD patients. Nonetheless, percent-
age distribution of patients with HAD levels (>10)
suggestive for anxiety and depression at admission
(not higher than 30% of the total sample) in our
study was quite similar to that of WITHERS et al.
[8], thus suggesting that exacerbation might have
influenced the score but not the prevalence of
symptoms within our study population.
At difference with previous study [8], it is
noteworthy that a similar improvement on anxiety
and depression following PR has been obtained in
a heterogeneous population of COPD (FEV1 rang-ing from 79 to 11% of predicted) although the
number of patients with an abnormal score (>10)
after iPR differently changed across groups (see
Results section). This change was higher in the
most compromised COPD (group 2 and 3). There-
fore, this result demonstrated that the most ob-
structed among COPD patients may benefit the
best from a comprehensive iPR on the associated
levels of anxiety and depression. Nonetheless, the
most severely impaired individuals are those who
may better improve their physiological outcomes
after pulmonary rehabilitation [24].
Recent research [25] has shown that higher
levels of catastrophic withdrawals coping strate-
gies and lower levels of self-efficacy of symptoms
management is associated with higher levels of de-
pression and a reduced quality of life in COPD pa-
tients.
Our study confirmed that poor correlation ex-
ists between HAD and the physiological measure-
ments in COPD patients [26, 27], whereas HAD
scores significantly related with SGRQ total com-
ponent (as assessed by absolute value or percent-
age change). HAJIRO et al. [18] have also found
that HAD score significantly correlated (r=0.51)
with SGRQ in mild and severe stable COPD pa-
tients.
The differences in correlation coefficients
recorded in that study [18] and in our study be-
tween HAD and SGRQ could be due to the differ-
ent condition of the patients included. However,
the finding of only partial correlation between
HAD and SGRQ scores probably means that psy-
chological features cannot be completely ex-
plained by dimensions linked with health-related
quality of life [28]. Therefore, future studies
should be better addressed to find the links (if any)
among these dimensions in order to maximize the
effects of PR by including more specific evalua-
tions and interventions.
The major limitation of the study are the folloing.
The overall improvement that we observed in our
sample should be interpreted with caution. Firstly,
iPR patients were not compared with a untreated
control group. However, these COPD patients were
specifically referred to our unit for rehabilitative pur-
pose, so it would have been unethical not to treat
them. Secondly, the positive effect of iPR could have
been mainly related to the continued medical im-
provement during convalescence. Nonetheless, the
gains in all the pre-determined outcome measures,
covering both physiological, psychological and
quality of life areas, were independent of the degree
of illness severity and suggested that iPR was prob-
ably the major causal factor. In addition, the mean
change in health-related quality of life scores paral-
leled and were (although weakly) significantly relat-
ed to those obtained in terms of anxiety and depres-
sion which have been previously shown as two of
the most important components of psychosocial im-
provement after PR [7]. Undoubtedly, the substantial
improvement observed in physiological variables
may have reflected the marked baseline limitations
(which was also a pre-determined criteria of study
entry) of this population. Finally, we did not fol-
lowed our patients after discharge to look at any
variation in the anxiety and depression status, possi-
bly related to the long-term effects of our iPR.
In conclusion, our study shows that iPR may
improve levels of anxiety and depression as well as
symptoms, exercise capacity and health related
quality of life in moderate to severe COPD patients
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after an acute exacerbation. Psychological measures
may be included as outcomes entering the compre-
hensive assessment that may quantify the burden of
COPD referred to inpatient rehabilitation.
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